CN103142518B - 一种阿格列汀脂质体固体制剂及其制备方法和应用 - Google Patents
一种阿格列汀脂质体固体制剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN103142518B CN103142518B CN201310057299.XA CN201310057299A CN103142518B CN 103142518 B CN103142518 B CN 103142518B CN 201310057299 A CN201310057299 A CN 201310057299A CN 103142518 B CN103142518 B CN 103142518B
- Authority
- CN
- China
- Prior art keywords
- egelieting
- liposome
- solid preparation
- cellulose
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310057299.XA CN103142518B (zh) | 2013-02-22 | 2013-02-22 | 一种阿格列汀脂质体固体制剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310057299.XA CN103142518B (zh) | 2013-02-22 | 2013-02-22 | 一种阿格列汀脂质体固体制剂及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103142518A CN103142518A (zh) | 2013-06-12 |
CN103142518B true CN103142518B (zh) | 2014-10-29 |
Family
ID=48541034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310057299.XA Active CN103142518B (zh) | 2013-02-22 | 2013-02-22 | 一种阿格列汀脂质体固体制剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103142518B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103353491B (zh) * | 2013-06-29 | 2018-11-16 | 北京万全德众医药生物技术有限公司 | 一种用液相色谱法分离测定苯甲酸阿格列汀原料及其制剂的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101817833A (zh) * | 2009-02-26 | 2010-09-01 | 中国科学院广州生物医药与健康研究院 | Dpp-iv抑制剂 |
-
2013
- 2013-02-22 CN CN201310057299.XA patent/CN103142518B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101817833A (zh) * | 2009-02-26 | 2010-09-01 | 中国科学院广州生物医药与健康研究院 | Dpp-iv抑制剂 |
Non-Patent Citations (2)
Title |
---|
磷脂药物制剂研究进展;陈闯等;《中国生化药物杂志》;20031231;第24卷(第2期);第98页第1.3栏 * |
陈闯等.磷脂药物制剂研究进展.《中国生化药物杂志》.2003,第24卷(第2期),第98页第1.3栏. |
Also Published As
Publication number | Publication date |
---|---|
CN103142518A (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019268052B2 (en) | Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose | |
CN103118662B (zh) | 制备冻干速溶多相剂型的方法 | |
ES2935792T3 (es) | Formas farmacéuticas orales de bendamustina y uso terapéutico de las mismas | |
ES2708955T3 (es) | Formulaciones orales de deferasirox | |
BR112013012245B1 (pt) | Comprimido compreendendo hcl de rilpivirina e fumarato de tenofovir disoproxila seu uso no tratamento profilático ou terapêutico de uma infecção por hiv | |
CN108201536A (zh) | 一种奥拉帕尼口服缓控释药物组合物及其用途 | |
JP2007510656A5 (zh) | ||
CN101972236A (zh) | 一种含吡非尼酮的缓释制剂 | |
WO2015071841A1 (en) | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
WO2007021032A1 (ja) | 正確な用量分割機能を有する製剤 | |
HUE026681T2 (en) | A slow release aceclofenac formulation that provides optimal pharmacological clinical effects even when administered once a day | |
CN108201534A (zh) | 一种瑞卡帕布口服缓控释药物组合物及其用途 | |
KR101277021B1 (ko) | 위체류 약물 전달시스템을 이용한 경구용 방출제어형 레바미피드-함유 이층정 제제 및 그 제조방법 | |
US8012506B2 (en) | Tannate compositions, methods of making and methods of use | |
CN110035751A (zh) | 一种维利帕尼缓控释药物组合物及其用途 | |
CN108938607A (zh) | 一种维生素k组合物及其制备方法、制剂和用途 | |
TWI535463B (zh) | 醫藥固形製劑用之包衣劑、醫藥用膜衣製劑及被覆醫藥固形製劑 | |
US20160008328A1 (en) | Stable Pharmaceutical Package Comprising Azilsartan Medoxomil | |
CN103142518B (zh) | 一种阿格列汀脂质体固体制剂及其制备方法和应用 | |
CN101862336B (zh) | 一种厄贝沙坦氢氯噻嗪药物组合物脂质体固体制剂 | |
CN102470121A (zh) | 包含决奈达隆的药物组合物 | |
BR112019014712A2 (pt) | Tratamento médio que compreende a administração entérica de edaravona | |
ES2963886T3 (es) | Comprimidos que contienen tamsulosina y solifenacina | |
WO2010087358A1 (ja) | 新規組成物 | |
TW202320774A (zh) | 用於口服之舒緩肽b2受體拮抗劑之基於脂質之組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: XIANQIANG PHARMACEUTICAL CO., LTD., GUANGDONG Free format text: FORMER NAME: GUANGDONG XIANQIANG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 510620 Guangdong Province, Guangzhou City Sports Road No. 103 A Victoria Plaza, 49 floor 4901 Patentee after: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. Address before: 510620 Guangdong Province, Guangzhou City Sports Road No. 103 A Victoria Plaza, 49 floor 4901 Patentee before: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20200910 Address after: 510000 No. 6 Industrial Avenue, Conghua Economic Development Zone, Guangzhou, Guangdong Province Co-patentee after: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. Patentee after: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. Address before: 510620 Guangdong Province, Guangzhou City Sports Road No. 103 A Victoria Plaza, 49 floor 4901 Patentee before: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221010 Address after: No.6, Industrial Avenue, Conghua Economic Development Zone, Guangzhou, Guangdong 510000 Patentee after: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. Address before: No.6, Industrial Avenue, Conghua Economic Development Zone, Guangzhou, Guangdong 510000 Patentee before: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. Patentee before: ASTATECH (CHENGDU) BIOPHARMACEUTICAL Corp. |
|
TR01 | Transfer of patent right |